glp-1 micro dose microdosing is popular, but there's little evidence it works Microdosing GLP-1 Medications | Achieve

doi: 10.3389/fnut.2025.1484827 Received 22 August 2024 Accepted 07 March 2025 Published 24 March 2025 Volume 12 - 2025 Edited by Eric Gumpricht, Independent Researcher, Gilbert, AZ, United States Reviewed by Chlo Berland, Universit Paris Cit, France Meng Zhao, University of California, Davis, United States Updates Copyright 2025 Sun, Liu, Yuan, Rong, Pang and Li

Pointer, K

It is verified that all IFS requirements for food quality and safety are met and is the highest level of certification for food/supplements

The impact of GEP12 on food intake relative to baseline was notably less than that observed in response to GEP44 (at 5 nmol/kg/day: mean difference 36.5%, 95% CI 14.9% to 58.0%, p = 0.0009

5. Propiedades y Proteccin Celular

BPC-157 has shown potential in aiding conditions like inflammatory bowel disease (IBD) due to its anti-inflammatory and gut-healing properties